Last update 06 Oct 2025

Icotrokinra

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
JNJ 67864238, JNJ-2113, JNJ-4238
+ [7]
Target
Action
inhibitors
Mechanism
IL-23R inhibitors(Interleukin 23 Receptor inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plaque psoriasisNDA/BLA
United States
21 Jul 2025
Colitis, UlcerativePhase 3
United States
23 Oct 2025
Colitis, UlcerativePhase 3
Japan
23 Oct 2025
Crohn DiseasePhase 3
United States
23 Oct 2025
Crohn DiseasePhase 3
Japan
23 Oct 2025
Arthritis, PsoriaticPhase 3
United States
09 Jan 2025
Arthritis, PsoriaticPhase 3
China
09 Jan 2025
Arthritis, PsoriaticPhase 3
Japan
09 Jan 2025
Arthritis, PsoriaticPhase 3
Argentina
09 Jan 2025
Arthritis, PsoriaticPhase 3
Australia
09 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
kbhocuiiae(vszcuasipu) = Icotrokinra showed superior skin clearance vs placebo (Week 16) and deucravacitinib (Weeks 16 and 24). dcfhoygiuc (ixjefsznxu )
Met
Superior
17 Sep 2025
Phase 3
-
Icotrokinra (re-randomized at Week 24)
tcswipbyxc(gqdddgpzdd) = aohwutsfxw neapybuvlh (tzffsniwvt )
Positive
17 Sep 2025
Placebo (re-randomized at Week 24)
tcswipbyxc(gqdddgpzdd) = hulpdgflbr neapybuvlh (tzffsniwvt )
Phase 3
-
rpdujjxfaf(ikytqsbzkr) = ckbmwqtrnc sedrhxbweg (anousgkzrk )
Positive
04 Aug 2025
Placebo
dmbtfhkgfl(vtbmbsfhbd) = xiiinexxzq hxtzldubmb (ooikdahmsp )
Phase 1
-
-
ozqdrpsgym(bmssetuybk) = zzowakjmzv nhdtekibfo (zkzihdhwwh )
Positive
08 Jul 2025
Placebo
ozqdrpsgym(bmssetuybk) = suctpajbwy nhdtekibfo (zkzihdhwwh )
Phase 3
684
mlerksppuf(unwgwkgomn): P-Value = <0.001
Positive
11 Jun 2025
Placebo
Phase 3
311
golyzcxmhe(lbgpqsoztw): P-Value = <0.001
Positive
11 Jun 2025
Placebo
Phase 3
311
xcayzyldfk(nkxuenxfln) = hgburnuyeh ftobqtjqji (uaehjdwsjs )
Met
Positive
09 May 2025
placebo
xcayzyldfk(nkxuenxfln) = kfyqvgezgl ftobqtjqji (uaehjdwsjs )
Met
Phase 3
-
vapsbbehbd(hhiybkpofn) = onqestngek ecqefdrvrn (xlrepjgkre )
Positive
10 Apr 2025
Placebo
vapsbbehbd(hhiybkpofn) = xmzkcpugbf ecqefdrvrn (xlrepjgkre )
Phase 2
252
frwaftyipp(tjccyxqutl) = qyxvnblwng phjfupffpf (oncrkmunqa )
Met
Positive
10 Mar 2025
Placebo
frwaftyipp(tjccyxqutl) = uupczwbafj phjfupffpf (oncrkmunqa )
Met
Phase 3
-
ipfvylordj(exxurhcpvm) = zxdykgylnd czdfinqscq (cyycxtztdq )
Met
Positive
18 Nov 2024
Placebo
ipfvylordj(exxurhcpvm) = amtoizwtvm czdfinqscq (cyycxtztdq )
Met
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free